DEPLOYDatabase

Robot model

EksoNR

Powered (motor-driven) lower-limb exoskeleton for clinical gait rehabilitation (stroke, spinal-cord injury, acquired brain injury).

Manufacturer
Ekso Bionics
Form factor
exoskeleton
Maturity
commercial
Lifecycle
active
Deployments
2

Overview

Powered (motor-driven) lower-limb exoskeleton for clinical gait rehabilitation (stroke, spinal-cord injury, acquired brain injury). User intent plus weight-shift triggers powered steps; the device powers the joints, the clinician/patient sets the session. FDA cleared.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Verified deployments
2 deployments on file
Sources on file
3 sources, view all

Key facts

Type

Exoskeleton for neurorehabilitation

Specs

Use

medical rehab

Control

weight-shift + user intent triggers powered steps

Powered

yes (motor-driven)

Runtime

8 h

Weight kg

25

Regulatory

FDA cleared

Body region

lower-limb

Availability

commercial

Data & sources

Press releases

1

Web sources

2

3 sources backing this record.View all →

Pricing

No verified price is on record for EksoNR. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

Deployments (2)

  • Ekso Bionics maintains a distribution and service facility in Ratingen, Germany to serve the EMEA market.

  • EksoNR is FDA-cleared for stroke, SCI, acquired brain injury, and multiple sclerosis (first exoskeleton cleared for MS, June 2022).

EksoNR on the deployment map

Where EksoNR is verified operating. Explore the deployment map by place and type.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Deployment-verified media (1)

PRIMARY SOURCE
Courtesy of Ekso Bionics

Ekso Bionics footage of a stroke patient performing clinician-supervised assisted stepping in the EksoNR rehabilitation exoskeleton. The device provides adaptive assistance and the patient initiates each step (the robot does not walk the patient), so it is not autonomous.

From deployment: Germany

Regulatory filings (1)

Safety record

No incidents on record for EksoNR.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (3)

  1. https://en.wikipedia.org/wiki/Ekso_Bionics
  2. https://www.eksobionics.com/
  3. https://eksobionics.com/eksonr/

Common questions

What is EksoNR?
Powered (motor-driven) lower-limb exoskeleton for clinical gait rehabilitation (stroke, spinal-cord injury, acquired brain injury). User intent plus weight-shift triggers powered steps; the device powers the joints, the clinician/patient sets the session. FDA cleared.
How much does EksoNR cost?
EksoNR's price is not publicly disclosed. DEPLOY has no verified price on record for EksoNR from Ekso Bionics. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is EksoNR actually deployed in the real world?
Yes. EksoNR is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
What are the specs of EksoNR?
EksoNR's recorded specifications on the DEPLOY registry: Runtime: 8 h; Weight: 25 kg. See the Specs section for the full sourced set.
Who makes EksoNR?
EksoNR is made by Ekso Bionics, based in Richmond, California, USA, founded in 2005.
Methodology: Verified · 3 sources (1 primary) · last reviewed 2026-07-15

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-07-15

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

1
knowledge-base
Knowledge base
1
unclassified
Unclassified source
1
primary-company-ir
Company IR disclosure

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for EksoNR.

Recent coverage

EksoNR in third-party press